Systemic Therapy for Primary Liver Tumors: Cholangiocarcinoma and Hepatocellular Carcinoma

Area of Science:

• Hepatology
• Oncology
• Molecular Biology

Background:

• Significant progress in primary liver cancer treatment over the last decade.
• Growing understanding of molecular alterations in liver tumors.

Purpose of the Study:

• To review the translation of molecular knowledge into patient care for primary liver cancer.
• To highlight the role of ongoing clinical trials in advancing therapeutic options.

Main Methods:

• Review of recent advancements in primary liver cancer treatment.
• Analysis of molecular alterations and their clinical translation.
• Discussion of ongoing clinical trials for targeted therapeutics and immunotherapy.

Main Results:

• Molecular understanding is increasingly guiding primary liver cancer patient care.
• New therapeutic strategies including molecular targeted therapeutics and immunotherapy are emerging.
• Clinical trials are crucial for validating and advancing these novel treatments.

Conclusions:

• The translation of molecular insights into clinical practice is transforming primary liver cancer treatment.
• Appropriate clinical application of new drugs is essential for optimizing outcomes and managing side effects.